ClinicalTrials.gov record
Completed Phase 4 Interventional

Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction

ClinicalTrials.gov ID: NCT00147654

Public ClinicalTrials.gov record NCT00147654. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 11:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double Blind, Placebo Controlled, Four Arm (Placebo, Tolterodine ER, Tamsulosin, and Tolterodine ER Plus Tamsulosin) Study To Evaluate The Clinical Efficacy And Safety Of Tolterodine ER 4 mg In Men Who Have Frequency and Urgency, With Or Without Urinary Urge Incontinence, With Or Without Bladder Outlet Obstruction

Study identification

NCT ID
NCT00147654
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Industry
Enrollment
830 participants

Conditions and interventions

Interventions

  • Tamsulosin 0.4 mg QD Drug
  • Tolterodine ER 4 mg QD Drug

Drug

Eligibility (public fields only)

Age range
40 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2004
Primary completion
Not listed
Completion
Apr 30, 2006
Last update posted
Jan 26, 2021

2004 – 2006

United States locations

U.S. sites
95
U.S. states
31
U.S. cities
95
Facility City State ZIP Site status
Pfizer Investigational Site Birmingham Alabama
Pfizer Investigational Site Homewood Alabama
Pfizer Investigational Site Tucson Arizona
Pfizer Investigational Site Anaheim California
Pfizer Investigational Site Culver City California
Pfizer Investigational Site Fresno California
Pfizer Investigational Site La Mesa California
Pfizer Investigational Site Long Beach California
Pfizer Investigational Site Los Angeles California
Pfizer Investigational Site Murrieta California
Pfizer Investigational Site Poway California
Pfizer Investigational Site San Bernardino California
Pfizer Investigational Site Santa Monica California
Pfizer Investigational Site Aurora Colorado
Pfizer Investigational Site Boulder Colorado
Pfizer Investigational Site Denver Colorado
Pfizer Investigational Site New Britain Connecticut
Pfizer Investigational Site Waterbury Connecticut
Pfizer Investigational Site Melbourne Florida
Pfizer Investigational Site Ocala Florida
Pfizer Investigational Site Pembroke Pines Florida
Pfizer Investigational Site Tallahassee Florida
Pfizer Investigational Site Wellington Florida
Pfizer Investigational Site Atlanta Georgia
Pfizer Investigational Site Columbus Georgia
Pfizer Investigational Site Roswell Georgia
Pfizer Investigational Site Melrose Park Illinois
Pfizer Investigational Site Evansville Indiana
Pfizer Investigational Site Jeffersonville Indiana
Pfizer Investigational Site Iowa City Iowa
Pfizer Investigational Site Overland Park Kansas
Pfizer Investigational Site Shreveport Louisiana
Pfizer Investigational Site Boston Massachusetts
Pfizer Investigational Site Brighton Massachusetts
Pfizer Investigational Site Watertown Massachusetts
Pfizer Investigational Site Columbia Missouri
Pfizer Investigational Site O'Fallon Missouri
Pfizer Investigational Site St Louis Missouri
Pfizer Investigational Site Missoula Montana
Pfizer Investigational Site Henderson Nevada
Pfizer Investigational Site Las Vegas Nevada
Pfizer Investigational Site Cherry Hill New Jersey
Pfizer Investigational Site Edison New Jersey
Pfizer Investigational Site Hamilton New Jersey
Pfizer Investigational Site Lawrenceville New Jersey
Pfizer Investigational Site Marlton New Jersey
Pfizer Investigational Site Mount Laurel New Jersey
Pfizer Investigational Site Sewell New Jersey
Pfizer Investigational Site Voorhees Township New Jersey
Pfizer Investigational Site Westhampton New Jersey
Pfizer Investigational Site Woodbury New Jersey
Pfizer Investigational Site Albuquerque New Mexico
Pfizer Investigational Site Albany New York
Pfizer Investigational Site Bay Shore New York
Pfizer Investigational Site Carmel New York
Pfizer Investigational Site Cortlandt Manor New York
Pfizer Investigational Site Garden City New York
Pfizer Investigational Site Manhasset New York
Pfizer Investigational Site New York New York
Pfizer Investigational Site Orchard Park New York
Pfizer Investigational Site Poughkeepsie New York
Pfizer Investigational Site Staten Island New York
Pfizer Investigational Site Syracuse New York
Pfizer Investigational Site Cincinnati Ohio
Pfizer Investigational Site Cleveland Ohio
Pfizer Investigational Site Columbus Ohio
Pfizer Investigational Site Oklahoma City Oklahoma
Pfizer Investigational Site Portland Oregon
Pfizer Investigational Site Allentown Pennsylvania
Pfizer Investigational Site Bala-Cynwyd Pennsylvania
Pfizer Investigational Site Bryn Mawr Pennsylvania
Pfizer Investigational Site Philadelphia Pennsylvania
Pfizer Investigational Site State College Pennsylvania
Pfizer Investigational Site Wynnewood Pennsylvania
Pfizer Investigational Site Providence Rhode Island
Pfizer Investigational Site Charleston South Carolina
Pfizer Investigational Site Greenwood South Carolina
Pfizer Investigational Site Greer South Carolina
Pfizer Investigational Site Prosperity South Carolina
Pfizer Investigational Site Saluda South Carolina
Pfizer Investigational Site Germantown Tennessee
Pfizer Investigational Site Milan Tennessee
Pfizer Investigational Site Arlington Texas
Pfizer Investigational Site Austin Texas
Pfizer Investigational Site Houston Texas
Pfizer Investigational Site San Antonio Texas
Pfizer Investigational Site Provo Utah
Pfizer Investigational Site Alexandria Virginia
Pfizer Investigational Site Arlington Virginia
Pfizer Investigational Site Charlottesville Virginia
Pfizer Investigational Site Fairfax Virginia
Pfizer Investigational Site Virginia Beach Virginia
Pfizer Investigational Site Spokane Washington
Pfizer Investigational Site Tacoma Washington
Pfizer Investigational Site Cheyenne Wyoming

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00147654, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 26, 2021 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00147654 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →